| Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis E D¢Andrea, AS Kesselheim, JM Franklin, EH Jung, SP Hey, E Patorno Cardiovascular diabetology 19 (1), 1-11, 2020 | 29 | 2020 |
| FDA and EMA biosimilar approvals EH Jung, A Sarpatwari, AS Kesselheim, MS Sinha Journal of general internal medicine 35 (6), 1908-1910, 2020 | 24 | 2020 |
| Desmopressin and the risk of hyponatremia: A population-based cohort study M Fralick, S Schneeweiss, CJD Wallis, EH Jung, AS Kesselheim PLoS medicine 16 (10), e1002930, 2019 | 20 | 2019 |
| Assessing the justification, funding, success, and survival outcomes of randomized noninferiority trials of cancer drugs: a systematic review and pooled analysis B Gyawali, FA Tessema, EH Jung, AS Kesselheim JAMA network open 2 (8), e199570-e199570, 2019 | 17 | 2019 |
| Do Large Pharma Companies Provide Drug Development Innovation? Our Analysis Says No EH Jung, A Engelberg, AS Kesselheim STAT, 2019 | 12* | 2019 |
| Two-year outcomes after variable duration of drug cessation in patients with maculopathy associated with pentosan polysulfate use EH Jung, A Lindeke-Myers, N Jain JAMA ophthalmology 141 (3), 260-266, 2023 | 9 | 2023 |
| Challenges and opportunities for biomarker validation SP Hey, E D'Andrea, EH Jung, F Tessema, J Luo, B Gyawali, ... The Journal of Law, Medicine & Ethics 47 (3), 357-361, 2019 | 9 | 2019 |
| Prevalence of publicly available expanded access policies E Jung, PJ Zettler, AS Kesselheim Clinical Pharmacology & Therapeutics 104 (5), 1016-1021, 2018 | 8 | 2018 |
| Getting Cost Discussions Right: Nudging Patients to Avoid Cognitive Pitfalls BR Rao, EH Jung, NW Dickert Circulation: Cardiovascular Quality and Outcomes 16 (1), e009447, 2023 | 4 | 2023 |
| Surrogate Endpoints and Drug Regulation: What is Needed to Clarify the Evidence SP Hey, WB Feldman, EH Jung, E D'Andrea, AS Kesselheim The Journal of Law, Medicine & Ethics 47 (3), 381-387, 2019 | 3 | 2019 |
| Phakomatous choristomas: a case report and review of literature EH Jung, SA Avila, AA Gordon, AG de la Garza, HE Grossniklaus Ophthalmic Plastic & Reconstructive Surgery 38 (4), 330-335, 2022 | 2 | 2022 |
| Novelty of Active Ingredients in High-Cost Brand-Name Drugs EH Jung, A Sarpatwari, AS Kesselheim Journal of General Internal Medicine 35, 2219-2221, 2020 | 1 | 2020 |
| A call for spaced repetition in medical education BN French, TO Marxen, S Akhnoukh, J Novack, K Van Anderlecht, ... The clinical teacher 21 (1), e13669, 2024 | | 2024 |
| Characteristics of Vitamin A Deficiency Retinopathy at a Tertiary Referral Center in the United States DA Levine, NE Mathew, EH Jung, J Yan, NJ Newman, P Thulasi, S Yeh, ... Ophthalmology Retina 8 (2), 126-136, 2024 | | 2024 |
| Immunoglobulin A vasculitis presenting as bilateral upper eyelid erythema: A case report and review of literature EH Jung, SA Avila, S Nastasi, HJ Kim Pediatric Dermatology 40 (4), 733-734, 2023 | | 2023 |
| Pentosan polysulfate maculopathy: 3-year outcomes from a prospective study of disease course following drug cessation EH Jung, A Lindeke-Myers, N Jain Investigative Ophthalmology & Visual Science 64 (8), 3657-3657, 2023 | | 2023 |
| Colopathy Associated with Pentosan Polysulfate Use EH Jung, W Zheng, RJ Weiss, NE Mathew, BI Meyer, A Nizam, H Iskandar, ... medRxiv, 2023.04. 03.23288071, 2023 | | 2023 |
| The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers A Draper, EH Jung, Y Cao, RP Atallah, J Switchenko, S Kane, ... Oncology 101 (4), 213-223, 2023 | | 2023 |
| Pentosan polysulfate maculopathy: Keep an eye out for this masquerader N Jain, EH Jung Canadian Eye Care Today, 22–25-22–25, 2022 | | 2022 |
| Poorly differentiated histology as a predictive biomarker in patients with advanced gastrointestinal (GI) cancers treated with immunotherapy. A Draper, E Jung, Y Cao, R Atallah, JM Switchenko, OB Alese Journal of Clinical Oncology 40 (4_suppl), 664-664, 2022 | | 2022 |
